EUVIMEDEUVIMED entdecken
Crossref

Erythropoietin and the erythropoietin receptor, and drug resistance and progression of the neoplastic disease

Dominika Leś, Maria Saduś-Wojciechowska, Tomasz Rutkowski, Andrzej Wygoda, Krzysztof Składowski

OncoReview · 2019

DOI: 10.24292/01.or.171218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoReview, 2019. Verfasst von Dominika Leś und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Leś, D., Saduś-Wojciechowska, M., Rutkowski, T., Wygoda, A., & Składowski, K. (2019). Erythropoietin and the erythropoietin receptor, and drug resistance and progression of the neoplastic disease. OncoReview. https://doi.org/10.24292/01.or.171218

Vancouver

Leś D, Saduś-Wojciechowska M, Rutkowski T, Wygoda A, Składowski K. Erythropoietin and the erythropoietin receptor, and drug resistance and progression of the neoplastic disease. OncoReview. 2019. doi:10.24292/01.or.171218

BibTeX
@article{Le2019,
  author = {Leś, Dominika and Saduś-Wojciechowska, Maria and Rutkowski, Tomasz and Wygoda, Andrzej and Składowski, Krzysztof},
  title = {Erythropoietin and the erythropoietin receptor, and drug resistance and progression of the neoplastic disease},
  journal = {OncoReview},
  year = {2019},
  doi = {10.24292/01.or.171218}
}
Kostenlos starten →